CASE Higher Ed on the Hill Newsletter – Is College Worth It?
Higher Ed on the Hill: Is College Worth It & Rep. Owens Introduces Bill to Enhance Access to Higher Education...
CASE Op-Ed in Daily Caller: Resignation Of Biden Official Who Bungled FAFSA Overhaul Offers Opportunity To Fix Higher Ed Policy
Students, parents, and taxpayers received some rare good news late last month from the Department of Education: Richard Cordray, a...
CASE Op-ed, RealClear Markets: Don’t Let the CFPB Shut Off Low-Income Access to Credit
Gerard Scimeca – Chairman, CASE May 17, 2019 – https://bit.ly/2Vvy2Nx The American economy is, if nothing else, a land of...
CASE Op-Ed, RealClear Markets: 5 Ways the CFPB Could Actually Help Consumers
Gerard Scimeca – CASE Chairman March 7, 2019 – https://bit.ly/2IUXued President Trump’s appointee to head the Consumer Financial Protection Bureau (CFPB),...
Kathy Kraninger is the Leader Consumers and U.S. Businesses Need at CFPB
This week, the Senate has a unique opportunity to stand up for consumers by confirming Kathy Kraninger to serve as...
CASE Op-Ed – RealClear Policy: To Protect Consumers, the BCFP Must Listen to Them
Matthew Kandrach – President, CASE October 12, 2918 – https://bit.ly/2CcBczJ Only one government agency is specifically tasked with consumer protection, in...
CASE Op-Ed – Washington Examiner: Kathy Kraninger Will Reform the CFPB and Bring Consumers Relief
Gerard Scimeca – Chairman, CASE October 5, 2018 – https://washex.am/2DYX2t2 President Trump’s nomination of Kathy Kraninger to head the Consumer Financial...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/